Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation.

MLA

Potkrajcic, Vlatko, et al. “Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation.” Current Oncology, vol. 31, no. 5, May 2024, pp. 2679–88. EBSCOhost, https://doi.org/10.3390/curroncol31050203.

APA

Potkrajcic, V., Gani, C., Fischer, S. G., Boeke, S., Niyazi, M., Thorwarth, D., Voigt, O., Schneider, M., Mönnich, D., Kübler, S., Boldt, J., Hoffmann, E., Paulsen, F., Mueller, A.-C., & Wegener, D. (2024). Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation. Current Oncology, 31(5), 2679–2688. https://doi.org/10.3390/curroncol31050203

Chicago

Potkrajcic, Vlatko, Cihan Gani, Stefan Georg Fischer, Simon Boeke, Maximilian Niyazi, Daniela Thorwarth, Otilia Voigt, et al. 2024. “Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation.” Current Oncology 31 (5): 2679–88. doi:10.3390/curroncol31050203.